Veteran Access Partnership with AcuityMD to expand access to Alpha-Stim for U.S. military veterans creates a channel to a specialized buyer segment and potential procurement through VA-wide or veteran-focused healthcare programs.

Clinical Differentiator Leverage the FDA-cleared cranial electrotherapy stimulation and patented waveform as a unique value proposition to pain, anxiety, and insomnia markets, positioning against pharmacologics and driving trial with clinics seeking non-pharmacologic options.

Strategic Acquisitions The Pulvinar Neuro acquisition signals a capability expansion into closed-loop and advanced neuromodulation solutions, suggesting cross-sell opportunities with mental health and neuromodulation 연구 centers and hospital systems exploring cutting-edge CES technology.

Expansion Signals Regular leadership appointments and roadmap momentum indicate ongoing investment and potential for larger contract opportunities, including hospital networks, integrators, and wound or pain management programs seeking non-drug therapies.

Mid-Market Fit Revenue range and employee size align with mid-market health tech distributors, contract manufacturers, and durable medical equipment suppliers, presenting opportunities for channel partnerships, OEM licensing, or co-marketing arrangements.